New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Flora Growth Corp.
FLGC
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

13M

Drug Manufacturers - Specialty & Generic

Next Earning date - 27 Mar 2025

13M

Drug Manufacturers - Specialty & Generic

Next Earning date - 27 Mar 2025

0.94USD

Shape-0.03 ( -2.64%)
Market Closed (as of Feb 19, 21:00 EDT)
favorite-chart

Relative Strenght

6
favorite-chart

Volume Buzz

-46%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

68%

Quote Panel

Shape
Updated March 26, 2025
1W 2.51 % 1M -15.88 % 3M -33.94 % 1Y -69.78 %

Key Metrics

Shape
  • Market Cap

    13.10M


  • Shares Outstanding

    19.44M


  • Share in Float

    12.67M


  • Dividende

    0


  • Earning Date

    27 Mar 2025


  • Price Target

    0.6738


  • Average Volume

    220379


  • Beta

    1.9888788


  • Range

    0.59-2.929


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.floragrowth.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

FLGC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$60M

Shape382%

2025-Revenue

$0.28

Shape2%

2025-EPS

$25M

Shape-575%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Hold

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Alliance Global Partners

downgrade

Previous: Buy

2024-08-15

Now: Neutral

Cantor Fitzgerald

initialise

Previous: Not converted

2022-08-08

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-3.00
vs -4.79

Q1.23

arrow
arrow

N/A

-0.60
vs -2.16

Q2.23

arrow
arrow

N/A

-0.31
vs -11.23

Q3.23

arrow
arrow

N/A

-0.05
vs -1.40

Q4.23

arrow
arrow

N/A

-0.17
vs -3.00

Q1.24

arrow
arrow

N/A

-0.28
vs -0.60

Q2.24

arrow
arrow

N/A

-0.22
vs -0.31

Q3.24

arrow
arrow

N/A

-0.24
vs -0.05

Q4.24

arrow
arrow

N/A

-0.17
vs -0.17

Q1.25

arrow
arrow

+111%

0.03
vs -0.28

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+141%

11.5M  vs 4.8M

Q1.23

arrow
arrow

+307%

20.1M  vs 4.9M

Q2.23

arrow
arrow

+115%

21.5M  vs 10M

Q3.23

arrow
arrow

+61%

17.3M  vs 10.8M

Q4.23

arrow
arrow

+56%

18M  vs 11.5M

Q1.24

arrow
arrow

-10%

18M  vs 20.1M

Q2.24

arrow
arrow

-27%

15.7M  vs 21.5M

Q3.24

arrow
arrow

-28%

12.5M  vs 17.3M

Q4.24

arrow
arrow

-25%

13.5M  vs 18M

Q1.25

arrow
arrow

-11%

16.1M  vs 18M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-22%

-0.22
vs -0.14

Q1.23

arrow
arrow

-7%

-0.07
vs -0.22

Q2.23

arrow
arrow

-407%

-4.07
vs -0.07

Q3.23

arrow
arrow

+9%

0.09
vs -4.07

Q4.23

arrow
arrow

-129%

-1.29
vs 0.09

Q1.24

arrow
arrow

-108%

-1.08
vs -1.29

Q2.24

arrow
arrow

-36%

-0.36
vs -1.08

Q3.24

arrow
arrow

-89%

-0.89
vs -0.36

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

33

33
vs 39

-15%

Q2.23

arrow
arrow

2

2
vs 33

-94%

Q3.23

arrow
arrow

1

1
vs 2

-50%

Q4.23

arrow
arrow

4

4
vs 1

300%

Q1.24

arrow
arrow

4

4
vs 4

NA

Q2.24

arrow
arrow

3

3
vs 4

-25%

Q3.24

arrow
arrow

3

3
vs 3

NA

Q4.24

arrow
arrow

3

3
vs 3

NA

Earnings Growth

Latest News